Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Muscular Atrophy 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2ER+ and AR+ Breast Cancer 2Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Cachexia 1Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × ostarine × Clear all
NCT01616758 2024-03-08

Phase II Study of GTx024 in Women With Metastatic Breast Cancer

GTx

Phase 2 Terminated
22 enrolled 5 charts
Breast

Breast Neoplasms

NCT05065411 2024-02-26

VERU-024

Veru Inc.

Phase 3 Terminated
5 enrolled
Breast

Breast Neoplasms

NCT04869943 2024-01-26

ARTEST

Veru Inc.

Phase 3 Terminated
52 enrolled
Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡